Literature DB >> 11083843

Human CD8(+) T cells specific for Mycobacterium tuberculosis secreted antigens in tuberculosis patients and healthy BCG-vaccinated controls in The Gambia.

S M Smith1, M R Klein, A S Malin, J Sillah, K Huygen, P Andersen, K P McAdam, H M Dockrell.   

Abstract

Intracellular flow cytometry analysis of perforin production by CD8(+) T cells showed levels were greatly reduced in tuberculosis (TB) patients compared to healthy controls. Reduced cytotoxic-T-lymphocyte activity was also obtained with CD8(+) T cells from TB patients compared to healthy controls in The Gambia. A change in antigen recognition was noted between the two groups of donors: in addition to recognition of Ag85A and Ag85B, as seen in healthy donors, a prominent ESAT-6 response was found in TB patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11083843      PMCID: PMC97828          DOI: 10.1128/IAI.68.12.7144-7148.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

Review 1.  Modern vaccines. Mycobacterial diseases.

Authors:  P E Fine; L C Rodrigues
Journal:  Lancet       Date:  1990-04-28       Impact factor: 79.321

2.  Immune response to Mycobacterium bovis bacille Calmette Guérin infection in major histocompatibility complex class I- and II-deficient knock-out mice: contribution of CD4 and CD8 T cells to acquired resistance.

Authors:  C H Ladel; S Daugelat; S H Kaufmann
Journal:  Eur J Immunol       Date:  1995-02       Impact factor: 5.532

3.  Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic.

Authors:  M C Raviglione; D E Snider; A Kochi
Journal:  JAMA       Date:  1995-01-18       Impact factor: 56.272

4.  Activation of human CD8+ alpha beta TCR+ cells by Mycobacterium tuberculosis via an alternate class I MHC antigen-processing pathway.

Authors:  D H Canaday; C Ziebold; E H Noss; K A Chervenak; C V Harding; W H Boom
Journal:  J Immunol       Date:  1999-01-01       Impact factor: 5.422

5.  Recall of long-lived immunity to Mycobacterium tuberculosis infection in mice.

Authors:  P Andersen; A B Andersen; A L Sørensen; S Nagai
Journal:  J Immunol       Date:  1995-04-01       Impact factor: 5.422

6.  Human T cell responses to the ESAT-6 antigen from Mycobacterium tuberculosis.

Authors:  P Ravn; A Demissie; T Eguale; H Wondwosson; D Lein; H A Amoudy; A S Mustafa; A K Jensen; A Holm; I Rosenkrands; F Oftung; J Olobo; F von Reyn; P Andersen
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

7.  Major histocompatibility complex class I-restricted T cells are required for resistance to Mycobacterium tuberculosis infection.

Authors:  J L Flynn; M M Goldstein; K J Triebold; B Koller; B R Bloom
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-15       Impact factor: 11.205

8.  Evidence for occurrence of the ESAT-6 protein in Mycobacterium tuberculosis and virulent Mycobacterium bovis and for its absence in Mycobacterium bovis BCG.

Authors:  M Harboe; T Oettinger; H G Wiker; I Rosenkrands; P Andersen
Journal:  Infect Immun       Date:  1996-01       Impact factor: 3.441

Review 9.  T cell response to Mycobacterium tuberculosis.

Authors:  I M Orme; P Andersen; W H Boom
Journal:  J Infect Dis       Date:  1993-06       Impact factor: 5.226

10.  Characterization of human Mycobacterium bovis bacille Calmette-Guérin-reactive CD8+ T cells.

Authors:  S M Smith; A S Malin; T Pauline; S E Atkinson; J Content; K Huygen; H M Dockrell
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

View more
  24 in total

1.  HLA-B*35-restricted CD8(+)-T-cell epitope in Mycobacterium tuberculosis Rv2903c.

Authors:  Michèl R Klein; Abdulrahman S Hammond; Steve M Smith; Assan Jaye; Pauline T Lukey; Keith P W J McAdam
Journal:  Infect Immun       Date:  2002-02       Impact factor: 3.441

2.  Decreased expression of perforin in CD8+ T lymphocytes in patients with Mycobacterium tuberculosis infection and its potential value as a marker for efficacy of treatment.

Authors:  Hongbin Jiang; Huili Gong; Qing Zhang; Jin Gu; Li Liang; Jun Zhang
Journal:  J Thorac Dis       Date:  2017-05       Impact factor: 2.895

Review 3.  Antigens for CD4 and CD8 T cells in tuberculosis.

Authors:  Cecilia S Lindestam Arlehamn; David Lewinsohn; Alessandro Sette; Deborah Lewinsohn
Journal:  Cold Spring Harb Perspect Med       Date:  2014-05-22       Impact factor: 6.915

4.  Pleural mesothelial cells promote expansion of IL-17-producing CD8+ T cells in tuberculous pleural effusion.

Authors:  X Li; Q Zhou; W B Yang; X Z Xiong; R H Du; J C Zhang
Journal:  J Clin Immunol       Date:  2013-01-09       Impact factor: 8.317

5.  Mycobacterium tuberculosis growth control by lung macrophages and CD8 cells from patient contacts.

Authors:  Claudia Carranza; Esmeralda Juárez; Martha Torres; Jerrold J Ellner; Eduardo Sada; Stephan K Schwander
Journal:  Am J Respir Crit Care Med       Date:  2005-10-06       Impact factor: 21.405

6.  T-cell responses to the Mycobacterium tuberculosis-specific antigen ESAT-6 in Brazilian tuberculosis patients.

Authors:  Fernando L L Cardoso; Paulo R Z Antas; Alexandre S Milagres; Annemieke Geluk; Kees L M C Franken; Eliane B Oliveira; Henrique C Teixeira; Susie A Nogueira; Euzenir N Sarno; Paul Klatser; Tom H M Ottenhoff; Elizabeth P Sampaio
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

7.  Evaluation of T-cell responses to novel RD1- and RD2-encoded Mycobacterium tuberculosis gene products for specific detection of human tuberculosis infection.

Authors:  Xiao-Qing Liu; Davinder Dosanjh; Hansa Varia; Katie Ewer; Paul Cockle; Geoffrey Pasvol; Ajit Lalvani
Journal:  Infect Immun       Date:  2004-05       Impact factor: 3.441

8.  Specific lytic activity against mycobacterial antigens is inversely correlated with the severity of tuberculosis.

Authors:  S S De La Barrera; M Finiasz; A Frias; M Alemán; P Barrionuevo; S Fink; M C Franco; E Abbate; M del C Sasiain
Journal:  Clin Exp Immunol       Date:  2003-06       Impact factor: 4.330

9.  Immunologic analysis of HIV-uninfected Taiwanese children with BCG-induced disease.

Authors:  Wen-I Lee; Fang-Chen Liang; Jing-Long Huang; Tang-Her Jaing; Chi-Huei Wang; Tzou-Yien Lin; Yhu-Chering Huang; Wei-Lun Huang; Ruwen Jou; Meng-Ying Hsieh; Ju-Hsin Chia; Tsu-Lan Wu
Journal:  J Clin Immunol       Date:  2008-12-13       Impact factor: 8.317

10.  The Mycobacterium tuberculosis complex-restricted gene cfp32 encodes an expressed protein that is detectable in tuberculosis patients and is positively correlated with pulmonary interleukin-10.

Authors:  Richard C Huard; Sadhana Chitale; Mary Leung; Luiz Claudio Oliveira Lazzarini; Hongxia Zhu; Elena Shashkina; Suman Laal; Marcus B Conde; Afrânio L Kritski; John T Belisle; Barry N Kreiswirth; José Roberto Lapa e Silva; John L Ho
Journal:  Infect Immun       Date:  2003-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.